Virus-Based Therapy Shrinks Tumors in Skin Cancer Patients
www.technologynetworks.com
A study highlights the effectiveness of Talimogene laherparepvec (TVEC) for basal cell carcinoma. The virus-based therapy reduced tumor size in 50% of cases, enabled complete tumor regression in a third and activated immune defenses.